post-dialysis urea determination allows a more accurate estimation of the effective dialysis dose.
Thus, special attention must be paid to sample timing for post-dialysis urea concentration. Shortly-delayed blood sampling (2 mm after the end of the session) should correct for vascular access and cardiopulmonary recirculation [9] . However, the internal resistance to urea transfer from different compartments, which explains a large part of the observed urea rebound, is further delayed [10, 11] . Consequently, late blood sampling (30 to 45 mm after the end of the session) has been recommended to obtain an equilibrated urea concentration, but such a delay is inconvenient in routine clinical practice.
To overcome this problem, Smye et al have suggested a third early intradialytic blood sample for urea (70 to 90 mm from the beginning) that may be used to calculate equilibrated post-dialysis urea concentration [12] . Indeed, the Smye model has proven accurate in the prediction of equilibrated urea [13, 14] . However, the requirements of this approach (a third blood sample and mathematical calculation) may limit its clinical application.
In a previous study concerning the determination of urea rebound using an on-line urea sensor on the ultrafiltrate outflow, the following observations were made: (1) rebound amplitude increased with session efficiency; (2) urea concentration reached a plateau 30 minutes post-session; (3) intradialytic urea concentration 30 minutes before the end of the session was equivalent to the post-dialysis equilibrated value. The present study was undertaken to validate this last observation [15] .
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Methods

Patients
Ten stable end-stage renal disease patients regularly treated in our unit were involved in this study after informed consent. Seven males and three females, with a mean age of 52.7 17.4 years and a mean dry body wt of 70.2 6.3 kg, were included. They all had arteriovenous fistulas able to deliver blood flows up to 400 ml/min.
Hemodiafi It ration
Hemodiafiltration was performed using the Multimat dialysis machine (Belico-Sorin, Mirandola, Italy) modified to deliver ultrapure dialysate and with an integrated Urea Monitoring System (UMS, Bellco-Sorin). The substitution fluid, derived from ultrapure dialysate, was produced on-line in a two-stage filtration process (ultrafilte and microfilter) and was subsequently infused into the venous drip chamber (post-dilution). In paired filtration dialysis system, a double-chamber hemodiafIlter splits convective and diffusive fluxes in such way that the ultrafiltrate comes out separately [16] . The urea concentration in the ultrafIltrate is basically equivalent to that of arterial blood water [17] . The used hemodiafilters were either Spiraflo SG3O (Bellco-Sorin; consisting of a 0.55 m2 polysulfone membrane hemofilter followed by a 1.35 m2 low-flux polysulfone hemodialyzer) or the combination of a HFTO5 high-flux polysulfone 0.55 m2 hemofilter (Beilco-Sorin) followed by a high-flux 1.8 m2 polysulfone hemodialyzer HF8O (Fresenius, Bad Homburg, Germany). Anticoagulation was achieved with standard heparin administered as an initial intravenous bolus followed by continuous infusion until one hour before the end of the session. For all patients, hemodiafiltration was performed thrice weekly over a fixed duration of 180 minutes followed by 60 minutes of isolated ultrafiltration at a low rate of 30 mI/mm. While keeping the session duration constant, at least three different efficiency regimens were applied for each patient: session 1, low range Kt/V; session 2, medium range Kt/V; session 3, high range Kt/V. The operational conditions were adapted to reach these targets, as described below. Desired weight loss was achieved by varying the amount of substitution fluid since the ultrafiltration was always maintained at a constant rate.
Low range Kt/V. This was defined as a blood flow rate of 200 mI/mm, dialysate flow rate of 500 mI/mm, and an ultrafiltration rate of 50 mI/mm; the hemodiafilter total surface area was 1.90 m2.
Hemofilter
Hemodialyzer Medium range KtIV. The medium range Kt/V was the same as above, except with a blood flow rate of 400 ml!min.
High range Kt/V This was defined as a blood flow rate of 400 mi/mm, dialysate flow rate of 700 mI/mm, ultrafiltration rate of 50 mi/mm, arid total surface area of the hemodiafilter 2.35 m2.
Technique for urea monitoring
Intra-and post-dialytic urea concentration was monitored continuously with the UMS placed on the ultrafiltrate outflow of the hemodiafiltration circuit ( Fig. 1 ). This integrated on-line urea monitoring device sensed urea concentration from the rise in conductivity following total urea degradation in its urease cartridge. An algorithm converted the conductivity increase into ultrafiltrate urea concentration, which also reflected serum urea concentration [171. Continuous urea monitoring was performed over the entire hemodiafiltration session and continued over the 60-minute post-dialytic period of isolated ultrafiltration, and was repeated in each patient for the three defined efficiency regimens. -LnR -3BW/BW
where LnR, BW, BW, and t represent respectively the slope of the natural logarithm of urea concentration decline measured continuously in the ultrafiltrate, dry body wt (in kg), pre-to post-dialysis decrease in body wt (in kg), and dialysis time (in hours). Normalized protein catabolic rate (nPCR) was calculated as suggested by Garred et al [19] . Urea rebound, in %, was calculated as: hemodiafiltration. The "total" recirculation, in %, rate was approximated as follows:
2 is for urea concentrations in the ultrafiltrate two minutes post-hemodiafiltration.
The in Figures 5, 6 , and 7. The "uncorrected" Kt/V values were approximatively 15% higher than those corrected for rebound. The Kt/V values calculated either with equilibrated urea concentration or its estimate correlated closely (Fig. 8) , supporting the validity of our method for calculating equilibrated or double-pool KtV.
The mean delta KtIV (difference between single-pool and equilibrated Kt/V) using [urea]UF er,d-30 for the three efficiency regimens (low, medium, and high range) were respectively 0.12 0.04, 0.20 0.03, and 0.28 0.03. These differences were compared to the delta Kt!V (single-pool minus equilibrated) Kt/V was obtained from the slope of [urealUF decline versus time for the three different efficiency regimens. In addition, Kt/V values calculated with immediate post-dialysis urea ("uncorrected or single-pool Kt/V") were compared to those calculated with equilibrated post-dialysis urea concentration or its estimate 30 minutes before the end (equilibrated Kt/V); results are presented equations incorporates correction factors for extracellular volume contraction and urea generation during dialysis [291. Despite such an improvement, their accuracy still depends significantly on post-dialysis urea sample timing. Thus, equilibrated post-dialysis urea concentration remains a key parameter for precise dialysis quantification even when using simple urea kinetic modeling. Smye et a! have proposed a reliable method to calculate equilibrated urea concentration [6, 13] , but its clinical application has been limited by the necessity of a third blood sample.
We propose a new, simple, and cost-effective method to predict post-dialysis equilibrated urea concentration. Continuous urea monitoring on the ultrafiltrate outflow confirmed that postdialysis urea rebound is complete at 30 minutes. Interestingly, it also showed that equilibrated urea concentration (30 mm after the session) is equivalent to urea concentration 30 minutes before ending the session. This last observation has been validated prospectively in 38 hemodiafiltration sessions over a wide range of dialysis efficiency; therefore, it should be equally reliable when applied to other dialytic modalities. Recently, a real-time twopool urea kinetic simulation system was implemented on a paired filtration dialysis fitted with an on-line urea concentration sensor, with the purpose of validating our observation [30, 311. As shown, KtIV uncorrected for rebound significantly overestimated effective dialysis dose, particularly with high efficiency regimens, whereas, the use of either equilibrated urea concentration or its estimate 30 minutes before the end of the session allowed accurate estimation of double-pool Kt/V. Furthermore, the differences between single-pool and equilibrated KtfVs obtained with urea 30 minutes before the end of the session were close to identity when compared to those obtained when using the [20] , and with the equation from Tattersall et a! [21] for each session; the results are shown in Figure 9 .
Discussion
Estimating the effective "dialysis dose" delivered to a patient should account for the multicompartment urea kinetics within the body [221. Urea rebound, consequent to this latter phenomenon, significantly alters post-dialysis urea concentration, therefore affecting "dialysis dose" estimation. Indeed, the immediate postdialysis or non-equilibrated urea concentration overestimates the delivered dose [23, 24], whereas the equilibrated or delayed concentration allows a more accurate assessment. An equilibrated urea sample, obtained by waiting an extra 30 minutes after the session, is inconvenient to patients and care providers. Alternative methods to estimate dialysis dose delivery more precisely have been proposed, such as direct dialysis quantification, by either total or partial dialysate collection, and by on-line urea monitoring [25] [26] [27] [28] .
Compared to initially released simplified formulas based on pre-and post-dialysis urea concentrations, the last generation of Delta KtJV (sp-eq) with [Urea] UFend-30 formulas from Daugirdas and Schneditz [20] and from Tattersall et al [21] .
In conclusion, equilibrated post-dialysis urea concentration accounting for rebound may be accurately predicted by the urea concentration obtained 30 minutes before the end of the session, as demonstrated by on-line urea monitoring. It has two major advantages: first, it obviates the necessity to wait an extra 30 minutes after treatment for a delayed sample; second, it avoids the third intradialytic blood sampling required when applying the Smye method since only two blood samples suffice with this approach. 
